Digoxin Tablet
Product Images NDC 59651-436

4 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Digoxin (NDC 59651-436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (62.5 mCg (0.0625 mg) (100 Tablet Bottle))

Package Label-principal Display Panel (62.5 mCg (0.0625 mg) (100 Tablet Bottle))
Digoxin Tablets, USP 62.5 mcg (0.0625 mg) oral tablets label from Aurobindo Pharma USA, Inc. It indicates the product contains 100 tablets, is Rx only, and includes storage instructions at 20° to 25°C. The label features the NDC 59651-436-01 and states the product is made in India by Aurobindo Pharma Limited.*
FDA Label Image

Package Label-principal Display Panel (125 mCg (0.125 mg) (100 Tablet Bottle))

Package Label-principal Display Panel (125 mCg (0.125 mg) (100 Tablet Bottle))
Digoxin Tablets USP 125 mcg (0.125 mg) oral tablets packaging label from Aurobindo Pharma Limited. The label indicates a bottle of 100 tablets with NDC 59651-437-01, including storage instructions and distributor information for Aurobindo Pharma USA, Inc., East Windsor, NJ. The label includes a barcode and safety instructions about the printed safety seal under the cap.*
FDA Label Image

Package Label-principal Display Panel (250 mCg (0.25 mg) (100 Tablet Bottle))

Package Label-principal Display Panel (250 mCg (0.25 mg) (100 Tablet Bottle))
Label for Digoxin Tablets USP 250 mcg (0.25 mg) oral tablets by Aurobindo Pharma Limited. The label indicates a 100-tablet count and includes storage instructions and cautions related to the safety seal. Distributed by Aurobindo Pharma USA, Inc., made in India. The NDC is 59651-438-01.*
FDA Label Image

Chemical Structure (Digoxin Str)

Chemical Structure (Digoxin Str)
Chemical structure diagram of Digoxin, illustrating its steroid nucleus with attached sugar moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.